FDA NDC Directory · JSON-LD · Markdown

Novolin N

NDC 0169-1834 · HUMAN OTC DRUG · INJECTION, SUSPENSION

Generic nameHuman Insulin
Labeler / ManufacturerNovo Nordisk
Marketing categoryBiologic License Application · App BLA019959
Dosage form / routeINJECTION, SUSPENSION · SUBCUTANEOUS
Active ingredientsINSULIN HUMAN (100 [iU]/mL)
Marketing started19910701
Package count2

External sources

Source: openFDA. Public-domain (CC0).